Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06659055 · ClinicalTrials.gov registry record · NA
Bone Mineral Density Agreement Study Between EOSedge™ Versus Traditional DXA
A NA study of Healthy and Indicated for EOSedge Imaging, sponsored by Alphatec Spine.
- Recruiting
- Registry status
- NA
- Development phase
- 214
- Enrollment target
- 4
- Study locations
NCT06659055: Recruiting NA study of Healthy and Indicated for EOSedge Imaging, sponsored by Alphatec Spine.
NCT06659055 is a NA study of Healthy and Indicated for EOSedge Imaging that is actively recruiting participants, run by Alphatec Spine. The registered enrollment target is 214 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (67% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06659055, a NA study of Healthy and Indicated for EOSedge Imaging, is actively recruiting participants, sponsored by Alphatec Spine.
- RECRUITING
- Registry status
- NA
- Development phase
- 214 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this research is to collect medical imaging data to allow for the comparison of bone mineral density measurements from two different types of low-dose x-ray exams, EOSedge and conventional DXA. The main question it aims to answer is: Is there agreement between the calculated T-scores between the 2 different types of x-ray exams?
Primary Outcome
Calculation of EOSedge BMD will be post-processed from the bi-planar EOSedge 2E radiographs, and is measured in g/cm² surface mass on four lumbar vertebrae (L1-L4) in the anteroposterior (AP) projection. BMD results from the conventional DXA system will be similarly acquired from the spine (AP L1-L4) exam, and the paired T-scores derived from the BMD results will be tested for statistical agreement across the two systems.
Conditions Studied
Interventions
- RADIATION DXA Imaging
- RADIATION EOSedge imaging
Study Locations (4)
Arizona
- Honor Health - Phoenix
California
- ATEC Carlsbad - Carlsbad
Tennessee
- ATEC Mephis - Memphis
Virginia
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 214 participants |
| Start Date | 2024-09-11 |
| Est. Completion | 2025-03 |
| Phase | NA |
What NCT06659055 shows while recruiting
NCT06659055 is an interventional study that assigns participants to a tested intervention. The registered 214 participants enrollment target is mid-sized for trials with a published cap, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (67% lower).
The record links to 2 conditions, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which DXA Imaging is the first listed.
NCT06659055 reports a single indexed study location in Arizona, California, Tennessee.
Frequently Asked Questions
What is clinical trial NCT06659055 about?
NCT06659055 is a clinical study titled "Bone Mineral Density Agreement Study Between EOSedge™ Versus Traditional DXA". The purpose of this research is to collect medical imaging data to allow for the comparison of bone mineral density measurements from two different types of low-dose x-ray exams, EOSedge and conventional DXA. The main question it aims to answer is: Is there agreement between the calculated T-scores...
What is the current status of trial NCT06659055?
This trial is currently recruiting. It is a NA study. The enrollment target is 214 participants. The study started on 2024-09-11. Estimated completion is 2025-03.
What conditions does trial NCT06659055 study?
This clinical trial studies the following conditions: Healthy, Indicated for EOSedge Imaging.
What interventions are being tested in trial NCT06659055?
The interventions under investigation include: DXA Imaging (RADIATION), EOSedge imaging (RADIATION).
Who is sponsoring clinical trial NCT06659055?
This trial is sponsored by Alphatec Spine, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06659055 being conducted?
This trial has 4 study locations across Arizona, California, Tennessee, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06659055's enrollment target sits among peer trials
214 113th of 1090 higher than 977 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
-
Oxalate and Citrate in Humans - Response to Citrate
RECRUITING · NA
-
CArdioMEtabolic Function and Reserve Capacity in Healthy Adults: The CAMERA Study
RECRUITING · NA
-
Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia
RECRUITING · NA
-
Medical Illustration Design Characteristic Evaluation
RECRUITING · NA
-
Sodium vs Potassium Education to Improve Vascular Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04030507 · 214 participants · NA
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
- NCT04421248 · 214 participants · Phase 4
Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder
- NCT04667520 · 214 participants · NA
Testing a Lifestyle Physical Activity Intervention for Women With Depression in Alcohol Treatment
- NCT05418868 · 214 participants · Phase 1
A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI